MELOTTI, Paola Maria
 Distribuzione geografica
Continente #
NA - Nord America 2.660
EU - Europa 2.361
AS - Asia 989
SA - Sud America 9
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 6.030
Nazione #
US - Stati Uniti d'America 2.636
GB - Regno Unito 1.064
CN - Cina 787
SE - Svezia 278
IT - Italia 259
IE - Irlanda 201
FR - Francia 188
FI - Finlandia 130
DE - Germania 126
VN - Vietnam 90
UA - Ucraina 40
KR - Corea 35
TR - Turchia 35
BE - Belgio 26
CA - Canada 22
AT - Austria 11
RU - Federazione Russa 11
IR - Iran 9
HK - Hong Kong 8
PL - Polonia 7
NL - Olanda 6
AU - Australia 5
BR - Brasile 4
IN - India 4
VE - Venezuela 4
ES - Italia 3
JO - Giordania 3
JP - Giappone 3
LV - Lettonia 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IL - Israele 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SG - Singapore 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CY - Cipro 1
EG - Egitto 1
EU - Europa 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 6.030
Città #
Southend 984
Chandler 594
Jacksonville 301
Woodbridge 299
Ann Arbor 220
Dublin 198
Houston 143
Verona 142
Ashburn 141
Beijing 127
New York 94
Jinan 92
Wilmington 83
Lawrence 73
Nanjing 73
Princeton 73
Shenyang 67
Dong Ket 61
Hebei 35
Nanchang 34
Tianjin 34
Helsinki 32
Seoul 32
Ningbo 31
Haikou 29
Lancaster 26
Zhengzhou 26
Brussels 25
Changsha 25
Guangzhou 24
Jiaxing 24
Sindelfingen 24
Taizhou 24
Hangzhou 23
Taiyuan 23
Fairfield 18
Falls Church 17
Seattle 15
Milan 14
Elora 12
Boardman 11
Los Angeles 10
Norwalk 10
Redwood City 10
Vienna 10
Washington 10
Bologna 9
Redmond 9
San Francisco 9
Toronto 9
Dongguan 8
Hong Kong 8
Lanzhou 7
Riva del Garda 7
Auburn Hills 6
Augusta 5
San Mateo 5
Woodland 5
Cambridge 4
Clearwater 4
London 4
Maracaibo 4
Villafranca di Verona 4
Yicheng 4
Amman 3
Fremont 3
Fuzhou 3
Groningen 3
Isola della Scala 3
Kemerovo 3
Lappeenranta 3
Leawood 3
Novokuznetsk 3
Palermo 3
Puxian 3
Riva 3
San Diego 3
Warsaw 3
Almere Stad 2
Andover 2
Ardabil 2
Boston 2
Canberra 2
Catanzaro 2
Changle 2
Chaoyang 2
Chicago 2
Civitavecchia 2
Dearborn 2
Düsseldorf 2
Edinburgh 2
Henderson 2
Hoboken 2
Izmir 2
Lansdale 2
Madrid 2
Magelang 2
Melbourne 2
Phoenix 2
Rawalpindi 2
Totale 4.570
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 159
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 126
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 124
Analysis of CFTR function in human monocytes 120
Detection of CFTR protein in human leukocytes by flow cytometry. 120
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 113
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 108
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 107
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 107
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 106
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 106
Combining standardized and new CFTR functional tests for diagnosis 103
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 100
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 99
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 99
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 96
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 96
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 95
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 94
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 94
Poster Session Abstracts 94
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 93
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 92
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 90
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 90
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 89
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 88
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 88
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 87
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors. 87
New clinical diagnostic procedures for cystic fibrosis in Europe. 86
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 86
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 86
20 In vivo monitoring of lung inflammation in CFTR–/– mice 85
null 84
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 84
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 84
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 83
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 81
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 80
In vivo monitoring of lung inflammation in CFTR-deficient mice 80
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 78
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 77
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 77
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 76
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 74
Poster Session Abstracts 74
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 74
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 73
Poster Session Abstracts 73
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 71
Poster Session Abstracts 70
RELEVANCE OF HLA-G IN CF 68
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 68
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 67
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 66
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 65
Oxidative stress and antioxidant therapy in cystic fibrosis 64
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 61
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 61
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 61
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 60
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 59
The role of macrophages and their scavenger receptors in cystic fibrosis 58
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 56
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 56
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 54
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 54
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 52
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 45
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 45
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 35
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 33
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 31
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 21
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 21
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 18
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 15
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 13
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 13
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 11
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 5
Totale 6.142
Categoria #
all - tutte 18.893
article - articoli 9.579
book - libri 0
conference - conferenze 9.314
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201971 0 0 0 0 0 0 0 0 0 0 26 45
2019/2020640 66 5 18 48 66 64 95 37 22 74 59 86
2020/2021728 94 134 37 91 65 50 15 32 26 2 82 100
2021/2022756 90 245 4 44 46 20 8 28 27 28 53 163
2022/20231.507 117 179 113 271 117 367 17 82 176 8 40 20
2023/2024667 54 57 51 83 79 162 33 62 38 46 2 0
Totale 6.142